Literature DB >> 12966920

[The genetic diversity of Mycobacterium tuberculosis and an assessment of risk factors of tuberculosis spread in Russia's Siberian region by molecular epidemiological methods].

O V Norkina1, V N Kinsht, I V Mokrousov, Iu N Kurunov, V A Krasnov, M L Filipenko.   

Abstract

Molecular epidemiology approaches provided for a new interpretation of the TB infection transmission dynamics, contributed to changing the focuses of attention and updated the monitoring practice. On the basis of 101 cases of isolates of Mycobacterium tuberculosis (MBT) complex sampled from 84 patients with pulmonary tuberculosis in the Siberian region, we proved that the independent methods of IS6110 RFLP genetic typing and VNTR-typing by five accurate repeat tandems of ETR A, B, C, D, and E bring about similar results and can be used in studying the MTB clonal structure population in the Siberian region for the purpose of defining the TB infection transmission dynamics. The most widespread genetic types were detected, i.e. Beeijing family strains, the S42 spoligotype, and the 31323 VNTR type, which account for 52.3% of all samples. The general parameters describing the epidemic process intensity were evaluated, i.e. those characterizing the strains (91.6%) and the transmission activity factor (72%). Consequently, each three of the four analyzed TB cases resulted from a recent transmission. However, there is a trend, within the analyzed samples, towards a higher percentage of clusterization in the age group ranging from 40 to 60. Such trend is typical of a prevalence of TB reactivation cases caused by MBT complex strains spread intensively in the discussed territory. As for the clusterized isolates, which are endemic for the territory, such data should be interpreted as a recent transmission only cautiously. 28.5% of the studied isolates are resistant to anti-TB drugs used in medical practice; and 35.7% of them are resistant to izoniazide and rifampicin, therefore, according to the WHO classification they are considered to be poly-antibiotics-resistant (PAR). No strict associations were found between the spectrum of antibiotics-resistance and any of genotypes, however, 30% of PAR strains are 32525 and 42525 types VNTR (spoligotype S1 or Beejing type).

Entities:  

Mesh:

Year:  2003        PMID: 12966920

Source DB:  PubMed          Journal:  Mol Gen Mikrobiol Virusol        ISSN: 0208-0613


  6 in total

1.  Molecular genetic analysis of Mycobacterium tuberculosis strains spread in different patient groups in St. Petersburg, Russia.

Authors:  E Chernyaeva; P Dobrynin; N Pestova; N Matveeva; V Zhemkov; A Kozlov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-08       Impact factor: 3.267

2.  Efficient differentiation of Mycobacterium tuberculosis strains of the W-Beijing family from Russia using highly polymorphic VNTR loci.

Authors:  O V Surikova; D S Voitech; G Kuzmicheva; S I Tatkov; I V Mokrousov; O V Narvskaya; M A Rot; D van Soolingen; M L Filipenko
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Insights into the origin, emergence, and current spread of a successful Russian clone of Mycobacterium tuberculosis.

Authors:  Igor Mokrousov
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

4.  Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine.

Authors:  Maya A Dymova; Oleksander O Liashenko; Petro I Poteiko; Valeriy S Krutko; Eugeny A Khrapov; Maxim L Filipenko
Journal:  BMC Infect Dis       Date:  2011-03-28       Impact factor: 3.090

5.  Proteomics for the Investigation of Mycobacteria.

Authors:  J A Bespyatykh; E A Shitikov; E N Ilina
Journal:  Acta Naturae       Date:  2017 Jan-Mar       Impact factor: 1.845

6.  Mycobacterium tuberculosis population in northwestern Russia: an update from Russian-EU/Latvian border region.

Authors:  Igor Mokrousov; Anna Vyazovaya; Tatiana Otten; Viacheslav Zhuravlev; Elena Pavlova; Larisa Tarashkevich; Valery Krishevich; Boris Vishnevsky; Olga Narvskaya
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.